As the summer season of 2020 peaked, amidst a swelling pandemic and the murder of George Floyd, a team of physicians and staff within the Yale Department of Internal Medicine’s Section of Infectious Diseases banded together with university historians and experts from the Poorvu Center for Teaching and Learning to create a space to address diversity, equity, and anti-racism. Initially spearheaded by Lydia Aoun-Barakat, MD, associate professor of medicine (infectious diseases), and Gerald Friedland, MD, professor emeritus (infectious diseases), the section established the Infectious Diseases Diversity, Equity, and Antiracism (ID2EA) consortium, which aims to address systemic racism, promote diversity, and promote equity within the infectious disease space both at Yale and beyond via interactive learning sessions.
- January 25, 2023Source: YaleNews
Two Yale labs will lead projects, in collaboration with other leading universities, tasked with developing new approaches to understand and combat pathogens.
- October 21, 2022
Yale Department of Internal Medicine’s Section of Infectious Diseases was recently awarded two grants from the National Institutes of Health to conduct research to better support older patients with HIV in Ukraine.
- August 09, 2022
Faculty members from the Yale School of Public Health (YSPH) and Yale School of Medicine (YSM) recently joined an interdisciplinary group of students and researchers in Kuala Lumpur for a summer boot camp on implementation science.
- June 29, 2022
Calming Nerves During COVID While Caring for Women with HIV
- June 29, 2022
Cynthia Frank, PhD, RN, clinical research nurse 3 (infectious diseases), and Susan Ardito, senior administrative assistant (pulmonary), were honored recently with Department of Internal Medicine Service Excellence Awards.
- June 28, 2022
Before COVID-19, some Yale researchers had worked for years in other vaccine development efforts focused on conquering some the world’s most malicious and deadly diseases. Those efforts continue on trajectories that may be reshaped by knowledge gained from the COVID-19 experience.
- May 10, 2022
As long COVID-19 emerged, here’s what researchers at Yale learned about the body’s immune response and mysterious symptoms affecting the brain.
- April 29, 2022
A five-step process calls for global viral surveillance, vaccines, antiviral drugs, reimagined cities, and global equity.
- April 26, 2022
COVID-19 may be primarily a respiratory illness, but its reach extends far beyond the lungs, with an impact that includes the brain. The neurologic and psychiatric complications of COVID-19 are incredibly diverse and sometimes persist long after patients recover from their initial infections.